Xin Hu is an Assistant Professor at Department of Public Health Sciences, University of Virginia, School of Medicine. She is a current research fellow at the American Cancer Society. Prior to joining the Department, she worked as a Research Associate at the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center and a Biostatistician at the Yale Center for Analytical Sciences.
Dr. Hu’s research focuses on cancer outcomes, health care quality and health disparities, and she specializes in leveraging causal inference methods with administrative health records, national survey data, and other secondary data sources to evaluate national health policies and conduct population-based health services research. Her current research agenda surrounds three areas: 1) organizational structures of oncology market such as vertical integration, 2) health policy evaluation in the cancer population, such as Medicaid expansion and opioid prescription policies, and 3) racial disparities in cancer care delivery and outcomes.
Her research has been published in JAMA Oncology, JAMA Network Open, Journal of National Cancer Institute, and Medical Care. She is serving on the editorial board of Health Services Research and has been a journal reviewer for JAMA Network Open, Medical Care, Health Services Research, and PLOS ONE.
PhD in Health Services Research and Health Policy, Emory University 2019-2023
MSPH in Health Services Research and Health Policy, Emory University, 2013-2015
Bachelor of Management in Public Service Administration, Fudan University, 2009-2013
- Population-based cancer linkage and administrative claims
- Health Policy
- Causal inference
- Cancer Disparities
- Comparative Effectiveness
Hu X, Lipscomb J, Jiang C, Graetz I. Vertical integration of oncologists and cancer outcomes and costs in metastatic Castration-Resistant prostate cancer. J Natl Cancer Inst. 2022 Dec 30:djac233. doi: 10.1093/jnci/djac233. (with editorial)
Hu X, Brock KE, Effinger KE, et al. Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescribing Guideline. JAMA Oncol. doi:10.1001/jamaoncol.2022.3744
Graetz I, Yarbrough CR, Hu X, Howard DH. Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist. JAMA Oncol. 2020 Jul 1.
Hu X, Kaplan C, Martin MY, Walker MS, Stepanski E, Schwartzberg L, Vidal G, Graetz I. Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer. Cancer Epidemiol Biomarkers Prev 2022; https://doi.org/10.1158/1055-9965.EPI-22-0692
Hu X, Walker MS, Stepanski E, Kaplan CM, Martin MY, Vidal GA, Schwartzberg LS, Graetz I. Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer. JAMA Netw Open. 2022 Aug 1;5(8):e2225485.
Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Netw Open. 2021 Jun 1.
Hu X, Ma J, Jemal A, et al. Suicide Risk Among Individuals Diagnosed With Cancer in the US, 2000-2016. JAMA Netw Open. 2023;6(1):e2251863. doi:10.1001/jamanetworkopen.2022.51863
Links to More Information:
Google Scholar profile: https://scholar.google.com/citations?user=4jNT9sAAAAAJ&hl=en
Personal Website: https://sites.google.com/view/xinhu
Twitter handle: @XinHuHEcon